ClinicalTrialsFinder

Head and Neck Squamous Cell Carcinoma (HNSCC) Clinical Trials in Portland, Oregon

1 recruitingPortland, Oregon

Showing 1–1 of 1 trials

Recruiting
Phase 2Phase 3

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Head and Neck Squamous Cell Carcinoma (HNSCC)
Inhibrx Biosciences, Inc410 enrolled88 locationsNCT06295731